TP53 and neoplasm: This maintains the stability of p53 thereby increasing tumor HLA class I expression via endoplasmic reticulum aminopeptidase 1121 up-regulation of tumor HLA expression and enhance the anti-tumor response of MDM2-specific T cells, which can effectively promote MDM232-46 peptide vaccine-induced T cell killing of tumor cells.120